SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001445305-13-002844
Filing Date
2013-11-07
Accepted
2013-11-07 17:26:49
Documents
5
Period of Report
2013-11-07
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a8-kasnprposter11x7x2013.htm 8-K 26601
2 EX-99.1 pressrelease11-7x2013.htm EX-99.1 13173
3 EX-99.2 asnposter112013.htm EX-99.2 3894
4 asnposter112013001.jpg GRAPHIC 2629424
5 ljpcpressrelease_image1.jpg GRAPHIC 21134
  Complete submission text file 0001445305-13-002844.txt   3696913
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 131201827
SIC: 2836 Biological Products, (No Diagnostic Substances)